Featured TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide Patients with obesity randomized to the drug had less subclinical leaflet thrombosis and paravalvular leak than controls. By L.A. McKeown March 19, 2026